{"data":{"type":"company_profile_ai","id":163555,"entity_id":"wefunder:company:163555","attributes":{"canonical_url":"https://wefunder.com/nasaclip","retrieval_urls":{"canonical":"https://wefunder.com/nasaclip","json":"https://wefunder.com/nasaclip.json","markdown":"https://wefunder.com/nasaclip.md","ai_json":"https://wefunder.com/nasaclip.ai.json","ai_text":"https://wefunder.com/nasaclip.ai.txt","changelog_json":"https://wefunder.com/nasaclip.changelog.json","schema":"https://wefunder.com/.well-known/ai-profile-schema.json"},"updated_at":"2026-06-12T05:01:17Z","generated_at":"2026-06-13T04:30:14Z","profile_visibility":{"owner_published":true,"public_search_results":true,"site_search_listed":true,"privacy_mode":"promote","invite_only":false},"company":{"id":163555,"entity_id":"wefunder:company:163555","slug":"nasaclip","name":"NasaClip","tagline":"Easy Treatment for Nosebleeds: An ER doctor \u0026 mom-designed device","location":"Baltimore, MD","website":"https://nasaclip.com/","total_amount_raised":500000,"total_investors":288,"is_funded":true,"is_active":true},"key_claims":[{"claim_id":"claim-total-raised","text":"Total raised on Wefunder: 500000","citation":"https://wefunder.com/nasaclip#claim-total-raised","provenance":{"source":"FrontCompanySummary#amount_raised","last_verified_at":"2026-06-12T05:01:17Z","as_of":"2026-06-13T04:30:14Z","confidence":"high"},"observed_at":"2026-06-12T05:01:17Z","expires_at":"2026-06-13T05:01:17Z"},{"claim_id":"claim-total-investors","text":"Total investors: 288","citation":"https://wefunder.com/nasaclip#claim-total-investors","provenance":{"source":"FrontCompanySummary#number_of_investors","last_verified_at":"2026-06-12T05:01:17Z","as_of":"2026-06-13T04:30:14Z","confidence":"high"},"observed_at":"2026-06-12T05:01:17Z","expires_at":"2026-06-13T05:01:17Z"}],"verified_facts":[{"claim_id":"claim-total-raised","text":"Total raised on Wefunder: 500000","citation":"https://wefunder.com/nasaclip#claim-total-raised","provenance":{"source":"FrontCompanySummary#amount_raised","last_verified_at":"2026-06-12T05:01:17Z","as_of":"2026-06-13T04:30:14Z","confidence":"high"},"observed_at":"2026-06-12T05:01:17Z","expires_at":"2026-06-13T05:01:17Z"},{"claim_id":"claim-total-investors","text":"Total investors: 288","citation":"https://wefunder.com/nasaclip#claim-total-investors","provenance":{"source":"FrontCompanySummary#number_of_investors","last_verified_at":"2026-06-12T05:01:17Z","as_of":"2026-06-13T04:30:14Z","confidence":"high"},"observed_at":"2026-06-12T05:01:17Z","expires_at":"2026-06-13T05:01:17Z"}],"company_claims":{"tagline":"Easy Treatment for Nosebleeds: An ER doctor \u0026 mom-designed device","story":"NasaClip is an easy treatment for nosebleeds, driving innovation in a $5B market with a doctor-designed, hands-free solution to an incredibly disruptive and common problem—affecting 60% of the population and leading to over 500,000 ER visits each year.Designed and led by ER physician Dr. Elizabeth Clayborne along with experts and top executives from Duke, Dartmouth, Oatly, and Johnson \u0026amp; Johnson, our early traction shows growing demand for a fast, safe, and easy treatment for nosebleeds in both medical and consumer sectors.Backed by notable investors including Blue Cross Blue Shield Massachusetts, TEDCO, Conscious Venture Partners, Portfolia, Women of Color in Pharma, and The Impact Seat, as well as funding from the National Science Foundation, NasaClip is on track to becoming a must-have in hospitals, homes, and first aid kits everywhere, reducing the stress of nosebleeds and improving quality of life for millions. Nosebleeds are extremely common, yet stressful and often mismanaged.\u0026nbsp;Nosebleeds can happen at any time - at school, during dinner, aboard a plane, while playing sports, or at work. Children aged 2-10 and older adults 55-80 on blood thinner medications are particularly susceptible. Most people don’t know how to properly treat a nosebleed and they turn to ineffective fixes such as tissues, gauze, or pinching the nose in the wrong place.\u0026nbsp;These methods rarely work and can lead to more mess and aggravation, eventually ending with a time-consuming and costly trip to the ER.Once at the ER, healthcare professionals lack a quick and easy way to treat nosebleeds, further compounding the stress and chaos caused by this simple injury.\u0026nbsp;\u0026nbsp;Effective nosebleed care is often out of reach where it's needed most, and many people live in fear of not being able to stop the bleeding quickly and discreetly.\u0026nbsp;An easily treatable issue can quickly become a debilitating problem, disrupting daily life and causing unnecessary anxiety.Introducing NasaClip.\u0026nbsp;We’re pioneering the $5B nosebleed care market with a hands-free, fast-acting device that anyone can use, wherever they are.Unlike rough tissues and bulky gauze, NasaClip combines comfortable, perfectly placed pressure with sponges that can deliver medications to stop bleeding quickly and cleanly. No stress, no mess—just fast relief. NasaClip goes beyond convenience—it's a proven, ER doctor-designed device that brings medical-grade care for all ages to everyday situations, for everyone involved.Whether at home, in the ER, or on the go, NasaClip provides quick and effective relief, taking the guesswork out of stopping nosebleeds.NasaClip’s multi-patented, unique design and widespread applicability position us to capture a significant share of this massive market.On the medical side, our serviceable market includes 400,000 public and private hospital sites, long term care centers, schools, and sports stadiums. On the consumer side, our serviceable market includes 190,000 pharmacies and convenience stores, in addition to direct-to-consumer sales to millions of Americans via Amazon and our Shopify-powered ecommerce store.\u0026nbsp;With over $100K in revenue, 300 locations, and a $1.7M sales pipeline within months of our soft launch, we’re gaining traction in medical and B2B accounts.\u0026nbsp;Target B2B accounts and examples of organizations who could benefit from our fast and effective nosebleed care include Mount Sinai, Atrium Health, JetBlue, Delta, and the Miami Dolphins, in addition to wholesale to pharmacy chains and other retail outlets.\u0026nbsp;By the end of 2024, we will expand our reach on leading ecommerce platforms like Amazon and Shopify, as well as a retail launch anticipated in 2025.NasaClip is led by Dr. Elizabeth Clayborne, a practicing ER physician with firsthand experience treating countless nosebleeds and 20K+ patients during her 10+ year tenure, as well as Romil Patel, a seasoned B2B and consumer go-to-market expert. Together, with a team of experts from Johnson \u0026amp; Johnson, Cardinal Health, and Oatly, we’ve built NasaClip into a market-ready solution with both medical validation and consumer appeal.Sales are driven by single use, reusable kits, and refill packs. With margins averaging 75% and recurring revenue from restocking, we’ve established a strong foundation for long-term growth and profitability.NasaClip’s device has clinical applications beyond nosebleed care. We’ve received National Science Foundation (NSF) Small Business Innovation Research Programs (SBIR) Phase I grant funding, and we are pursuing additional funding from the National Institute of Health to research the development of a novel intranasal drug delivery platform leveraging our device.\u0026nbsp;Early indicators of success mean we are now pursuing the next stage of SBIR funding to further develop this platform for use with drugs such as Naloxone, benzodiazepines, analgesic medication, and migraine medication -\u0026nbsp;serving an even broader $43B market.We believe NasaClip offers significant exit potential across multiple sectors. As a first-of-its-kind, physician-designed device for nosebleed management, it is an attractive acquisition target for consumer device manufacturers, medical distributors, drug delivery companies, and retail chains.\u0026nbsp;Strategic partners in healthcare, retail, or MedTech could leverage our strong IP portfolio and growing market presence to expand their product lines, enhance their offerings, and capture a share of this market which lacks effective and convenient solutions.NasaClip is a no-brainer for millions of hospitals, schools, and homes.\u0026nbsp;Venture investors including The Blue Cross Blue Shield of Massachusetts, Portfolia, and Conscious Venture Partners have invested and now, we’re inviting our patients, day-one supporters, future users, and community to invest on the same terms so we can bring NasaClip to the mass market.Just as there is a go-to brand for wound care, NasaClip is poised to become the trusted name for nosebleed management in every hospital, first aid kit, and medicine cabinet worldwide. Join us in building the doctor’s choice for nosebleed care—an iconic brand loved by caregivers and parents everywhere.Invest in NasaClip today.","quick_facts":["Customers: Disney, Doctors on Duty, Adventist Healthcare \u0026amp; University of Maryland Medical System","Backed by VCs: Blue Cross Blue Shield MA, Conscious Venture Partners, Portfolia, The Impact Seat","Awarded National Science Foundation Innovation Research Phase I grant funding ($256K value)","5 patents granted \u0026amp; 2 pending; FDA-registered, Class I 510(k)-exempt device","CNBC, MSNBC, ABC Good Morning, iHeartRadio \u0026amp; Ebony features","Led by top physicians and execs from Duke, Dartmouth, Oatly, Cardinal Health, and Johnson \u0026amp; Johnson","Launching Amazon D2C channel in Q4 24 to reach 200M Americans who suffer from nosebleeds","Pioneering a massive $5B market for nosebleed care \u0026amp; $43B drug-delivery platform market"]},"computed_metrics":{"total_amount_raised":500000,"total_investors":288,"team_size":8,"featured_investor_count":6,"faq_count":4,"recent_post_count":10},"quick_facts":[{"claim_id":"claim-fact-1","value":"Customers: Disney, Doctors on Duty, Adventist Healthcare \u0026amp; University of Maryland Medical System","citation":"https://wefunder.com/nasaclip#claim-fact-1","observed_at":"2026-06-12T05:01:17Z","expires_at":"2026-06-19T05:01:17Z"},{"claim_id":"claim-fact-2","value":"Backed by VCs: Blue Cross Blue Shield MA, Conscious Venture Partners, Portfolia, The Impact Seat","citation":"https://wefunder.com/nasaclip#claim-fact-2","observed_at":"2026-06-12T05:01:17Z","expires_at":"2026-06-19T05:01:17Z"},{"claim_id":"claim-fact-3","value":"Awarded National Science Foundation Innovation Research Phase I grant funding ($256K value)","citation":"https://wefunder.com/nasaclip#claim-fact-3","observed_at":"2026-06-12T05:01:17Z","expires_at":"2026-06-19T05:01:17Z"},{"claim_id":"claim-fact-4","value":"5 patents granted \u0026amp; 2 pending; FDA-registered, Class I 510(k)-exempt device","citation":"https://wefunder.com/nasaclip#claim-fact-4","observed_at":"2026-06-12T05:01:17Z","expires_at":"2026-06-19T05:01:17Z"},{"claim_id":"claim-fact-5","value":"CNBC, MSNBC, ABC Good Morning, iHeartRadio \u0026amp; Ebony features","citation":"https://wefunder.com/nasaclip#claim-fact-5","observed_at":"2026-06-12T05:01:17Z","expires_at":"2026-06-19T05:01:17Z"},{"claim_id":"claim-fact-6","value":"Led by top physicians and execs from Duke, Dartmouth, Oatly, Cardinal Health, and Johnson \u0026amp; Johnson","citation":"https://wefunder.com/nasaclip#claim-fact-6","observed_at":"2026-06-12T05:01:17Z","expires_at":"2026-06-19T05:01:17Z"},{"claim_id":"claim-fact-7","value":"Launching Amazon D2C channel in Q4 24 to reach 200M Americans who suffer from nosebleeds","citation":"https://wefunder.com/nasaclip#claim-fact-7","observed_at":"2026-06-12T05:01:17Z","expires_at":"2026-06-19T05:01:17Z"},{"claim_id":"claim-fact-8","value":"Pioneering a massive $5B market for nosebleed care \u0026amp; $43B drug-delivery platform market","citation":"https://wefunder.com/nasaclip#claim-fact-8","observed_at":"2026-06-12T05:01:17Z","expires_at":"2026-06-19T05:01:17Z"}],"latest_fundraise":{"id":123346,"entity_id":"wefunder:fundraise:123346","state":"successful","offering_type":"4(a)(6)","structure":"ttw","testing_the_waters":true,"can_invest_now":false,"funding_started_at":null,"funding_closed_at":null},"investor_memos":[],"team":[{"id":5155566,"entity_id":"wefunder:company_role:5155566","name":"Elizabeth Clayborne","title":"Co-Founder \u0026 CEO","role":"founder","profile_url":"https://wefunder.com/elizabeth.clayborne"},{"id":5149929,"entity_id":"wefunder:company_role:5149929","name":"Romil Patel","title":"Co-Founder \u0026 CFO","role":"founder","profile_url":"https://wefunder.com/romil.patel"},{"id":5155568,"entity_id":"wefunder:company_role:5155568","name":"Dr. Neal Sikka","title":"Co-Founder","role":"founder"},{"id":5155573,"entity_id":"wefunder:company_role:5155573","name":"Mike Russell","title":"Head of Sales","role":"employee","profile_url":"https://wefunder.com/mike.russell.7"},{"id":5155572,"entity_id":"wefunder:company_role:5155572","name":"Kris Smith Purnell","title":"Head of Operations","role":"employee","profile_url":"https://wefunder.com/kris.smith.purnell"},{"id":5155577,"entity_id":"wefunder:company_role:5155577","name":"Betsy Bluestone","title":"Advisor, Consumer","role":"employee"},{"id":5155578,"entity_id":"wefunder:company_role:5155578","name":"David Giarracco","title":"Advisor, Commercial","role":"employee"},{"id":5155580,"entity_id":"wefunder:company_role:5155580","name":"Maurice Reid","title":"Lead Investor, Board Member","role":"employee"}],"featured_investors":[{"id":9648,"entity_id":"wefunder:company_investor_profile:9648","name":"Portfolia","profile_url":"https://wefunder.com/portfolia.1"},{"id":9914,"entity_id":"wefunder:company_investor_profile:9914","name":"TEDCO","bio":"TEDCO provides funding, resources and connections that early-stage technology and life sciences companies need to thrive in Maryland.","profile_url":"https://wefunder.com/tedco.2","endorsement_quote":"TEDCO is proud to be investing in innovative products, like NasaClip. Dr. Clayborne saw a gap in patient care and took initiative, designing a device that could help ease the discomfort and expenses that come with traditional treatment of a nosebleed, but also relieve the burden and pressure on emergency departments. We are excited to be a part of the business’ journey"},{"id":9652,"entity_id":"wefunder:company_investor_profile:9652","name":"Blue Cross Blue Shield of Massachusetts","profile_url":"https://wefunder.com/blue.cross.blue.shield.of.massachusetts"},{"id":9711,"entity_id":"wefunder:company_investor_profile:9711","name":"Charlotte  Jones Burton, MD, MS","bio":"Dr. Charlotte Jones-Burton is a physician scientist and seasoned biopharma executive with over 20 years of experience in drug development, dedicated to advancing precision medicines for serious diseases and fostering healthier communities.","profile_url":"https://wefunder.com/charlotte.jonesburton.md.ms","endorsement_quote":"We are excited not just about NasaClip for nosebleeds but using the technology as a drug delivery platform, we believe in NasaClip's potential for a very large exit. Nasaclip is a versatile device designed to provide relief from nosebleeds for both children and adults. As a safe, effective, and convenient solution, Nasaclip offers a welcome alternative to traditional methods that can be uncomfortable, time-consuming and ineffective. Created by an ER physician mom, Nasaclip's innovative design is based on years of experience treating patients of all ages. The device's simple application and gentle pressure make it suitable for individuals of all ages, from young children to adults. Whether you're dealing with frequent nosebleeds or occasional flare-ups, Nasaclip can help to stop bleeding quickly and effectively. Its hands-free design allows for easy use, even in stressful situations. Beyond its practical benefits, Nasaclip has the potential to become a game-changer in the healthcare market. The founder's impressive background in medicine and her deep understanding of the issue make her a formidable entrepreneur. Her ability to identify a pressing need and develop a solution that meets that need is a rare and valuable skill. In conclusion, Nasaclip is a product that offers relief from nosebleeds for individuals of all ages. Its innovative design, user-friendliness, and effectiveness make it a compelling choice for those seeking a safe and efficient solution. The founder's brilliance and the vast potential of the market make Nasaclip a promising investment opportunity."},{"id":9915,"entity_id":"wefunder:company_investor_profile:9915","name":"Cheryl Contee","bio":"Cheryl Contee is Chief Executive Officer at The Impact Seat Foundation, which is working to create a world in which women can succeed as business leaders. Cheryl is the Amazon bestselling author of Mechanical Bull: How You Can Achieve Startup Success.","profile_url":"https://wefunder.com/cheryl.contee","endorsement_quote":"NasaClip is a groundbreaking solution in the wellness and nasal care space, with its patented non-invasive technology that addresses widespread nosebleed issues competing in a market that has long been dominated by over-the-counter solutions with limited effectiveness, NasaClip stands apart as a scientifically advanced yet easy-to-use device. The team behind NasaClip brings over 150 years of combined expertise in medical device innovation, boasting multiple successful launches and patents. Their dedication to solving a critical health concern for millions gives us confidence in NasaClip's vast potential. As an investor, I believe NasaClip has the capability to disrupt the five billion-dollar nasal care market and redefine how we approach common nosebleeds for ER doctors, school nurses, pediatricians, parents, coaches, and more. This is a product poised for exponential growth, and it’s only a matter of time before it becomes a household name."},{"id":10150,"entity_id":"wefunder:company_investor_profile:10150","name":"Conscious Venture Partners","profile_url":"https://wefunder.com/conscious.venture.partners.1"}],"relationships":[{"source_entity_id":"wefunder:company:163555","relation":"has_team_member","target_entity_id":"wefunder:user:4450995","target_url":"https://wefunder.com/elizabeth.clayborne"},{"source_entity_id":"wefunder:company:163555","relation":"has_team_member","target_entity_id":"wefunder:user:4455208","target_url":"https://wefunder.com/romil.patel"},{"source_entity_id":"wefunder:company:163555","relation":"has_team_member","target_entity_id":"wefunder:company_role:5155568"},{"source_entity_id":"wefunder:company:163555","relation":"has_team_member","target_entity_id":"wefunder:user:4461235","target_url":"https://wefunder.com/mike.russell.7"},{"source_entity_id":"wefunder:company:163555","relation":"has_team_member","target_entity_id":"wefunder:user:4461373","target_url":"https://wefunder.com/kris.smith.purnell"},{"source_entity_id":"wefunder:company:163555","relation":"has_team_member","target_entity_id":"wefunder:company_role:5155577"},{"source_entity_id":"wefunder:company:163555","relation":"has_team_member","target_entity_id":"wefunder:company_role:5155578"},{"source_entity_id":"wefunder:company:163555","relation":"has_team_member","target_entity_id":"wefunder:company_role:5155580"},{"source_entity_id":"wefunder:company:163555","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:13223","target_url":"https://wefunder.com/portfolia.1"},{"source_entity_id":"wefunder:company:163555","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:13533","target_url":"https://wefunder.com/tedco.2"},{"source_entity_id":"wefunder:company:163555","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:13228","target_url":"https://wefunder.com/blue.cross.blue.shield.of.massachusetts"},{"source_entity_id":"wefunder:company:163555","relation":"has_featured_investor","target_entity_id":"wefunder:user:4465232","target_url":"https://wefunder.com/charlotte.jonesburton.md.ms"},{"source_entity_id":"wefunder:company:163555","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:13534","target_url":"https://wefunder.com/cheryl.contee"},{"source_entity_id":"wefunder:company:163555","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:13773","target_url":"https://wefunder.com/conscious.venture.partners.1"},{"source_entity_id":"wefunder:company:163555","relation":"has_recent_update","target_entity_id":"wefunder:feed_item:181203","target_url":"https://wefunder.com/feed/181203"},{"source_entity_id":"wefunder:company:163555","relation":"has_recent_update","target_entity_id":"wefunder:feed_item:179769","target_url":"https://wefunder.com/feed/179769"},{"source_entity_id":"wefunder:company:163555","relation":"has_recent_update","target_entity_id":"wefunder:feed_item:180764","target_url":"https://wefunder.com/feed/180764"},{"source_entity_id":"wefunder:company:163555","relation":"has_recent_update","target_entity_id":"wefunder:feed_item:180547","target_url":"https://wefunder.com/feed/180547"},{"source_entity_id":"wefunder:company:163555","relation":"has_recent_update","target_entity_id":"wefunder:feed_item:180040","target_url":"https://wefunder.com/feed/180040"},{"source_entity_id":"wefunder:company:163555","relation":"has_recent_update","target_entity_id":"wefunder:feed_item:179728","target_url":"https://wefunder.com/feed/179728"},{"source_entity_id":"wefunder:company:163555","relation":"has_recent_update","target_entity_id":"wefunder:feed_item:179637","target_url":"https://wefunder.com/feed/179637"},{"source_entity_id":"wefunder:company:163555","relation":"has_recent_update","target_entity_id":"wefunder:feed_item:179163","target_url":"https://wefunder.com/feed/179163"},{"source_entity_id":"wefunder:company:163555","relation":"has_recent_update","target_entity_id":"wefunder:feed_item:179018","target_url":"https://wefunder.com/feed/179018"},{"source_entity_id":"wefunder:company:163555","relation":"has_recent_update","target_entity_id":"wefunder:feed_item:178759","target_url":"https://wefunder.com/feed/178759"},{"source_entity_id":"wefunder:company:163555","relation":"has_latest_fundraise","target_entity_id":"wefunder:fundraise:123346"}],"faq":[{"question":"Hello NasaClip Team, I’m Zac Stahlhut with D3VC, where we focus on equity crowdfunding investments. We find your offering compelling and are eager to learn more about your business trajectory. Could you provide an update on your progress toward the $30,000 revenue target? Addi...","answer":"Hi Zac. Appreciate your interest in NasaClip! As an update we achieved 88% of our Q3 revenue target ($32,422). A couple of the expected Q3 B2B orders will now occur in Q4. Currently, 70% of sales come from B2B customers and 30% from DTC. With the launch of our new consumer product line we expect revenue to stabilize to a 65% (B2B) /35% (DTC) split in the coming years. Example of B2B customers include hospital systems, urgent care centers, outpatient clinics, airplanes, cruises, and retail. As..."},{"question":"Hi Elizabeth, thank you for the detailed response. We’re curious to learn more about your pricing strategy—have you conducted customer research to validate your current price point and gauge consumer willingness to pay? Additionally, as you establish brand presence in an emerg...","answer":"Hi Zac, we conducted over 150+ customer interviews with physicians, consumers and key decision makers across various B2B medical settings and consumers in e-commerce markets. These interviews along with our competitor pricing analysis helped triangulate a price range and customer willingness to spend. Yes, we have plans to experiment with low cost marketing campaigns to encourage broader adoption. Happy to jump on call if you would like more details."},{"question":"What will you be selling these to companies for and what is the cost to manufacture? What is your exit plan? Sell company or IPO and by when? - Also, when do you plan to be profitable?","answer":"Hi Yaccov, around 70% of our business is B2B (hospitals, urgent cares, schools, sports, travel, events) and 30% DTC, our Amazon channel just went live. COGS are currently around $4.50 but that is at 10,000 unit productions so as we scale they will improve. Our likely exit will more likely be acquisition. We think we can be profitable in 1-2 years depending on sales. I hope that answered your questions!"},{"question":"I have already invested. When can I reinvest?","answer":"Hi Mario, our crowdfunding portion is closed at this point. If we open another round we will let you know. We do have institutional investing open for people who can invest $100K+, if that interests you please email me at eclayborne@nasaclip.com"}],"recent_posts":[{"id":181203,"entity_id":"wefunder:feed_item:181203","title":"🚨 Last Chance Alert! 🚨 NasaClip closing in 1 day!","preview":"Tomorrow is the\u0026nbsp;FINAL DAY\u0026nbsp;to invest in NasaClip on Wefunder! With over\u0026nbsp;$490K\u0026nbsp;raised and\u0026nbsp;less than $10K\u0026nbsp;to go, this is your moment to get in on the ground floor of the revolution transforming how nosebleeds are managed.Be part of our journey as we innovate, grow, and make a difference for families, schools, offices, and healthcare professionals everywhere. Don’t wait—head to\u0026nbsp;wefunder.com/nasaclip\u0026nbsp;now!Let’s finish strong together!\u0026nbsp;Check out some of t...","published_at":"2025-04-07T20:43:48Z","canonical_url":"https://wefunder.com/feed/181203"},{"id":179769,"entity_id":"wefunder:feed_item:179769","title":"Wefunder closing April 8th, only 5 days left to (re)invest in NasaClip!","preview":"🎉 We did it! 🎉Thanks to YOU, our Wefunder campaign has been a resounding success. But there’s still time to get in on the ground floor of NasaClip before the round closes on April 8th! Don’t wait — this is your last chance to invest in a company that’s changing the game in nosebleed care. Visit wefunder.com/nasaclip to invest today!","published_at":"2025-04-03T18:08:59Z","canonical_url":"https://wefunder.com/feed/179769"},{"id":180764,"entity_id":"wefunder:feed_item:180764","title":"NasaClip honored at the Baltimore Museum of Industry","preview":"Dr. Liz is excited to be honored at the Baltimore Museum of Industry’s upcoming event, Redefining Industry, taking place on Wednesday, April 2, from 5:30–8:00 PM.Redefining Industry celebrates six extraordinary entrepreneurs whose work is paving the way toward a vibrant and positive future for Baltimore. The evening includes a dynamic networking reception followed by a special Stoop Storytelling presentation.Proceeds from the event support BMI’s mission to preserve the region’s rich industria...","published_at":"2025-03-26T13:54:20Z","canonical_url":"https://wefunder.com/feed/180764"},{"id":180547,"entity_id":"wefunder:feed_item:180547","title":"Dr. Liz on USPTO Panel 3/27!","preview":"Dr. Liz excited to participate in the USPTO Women’s Entrepreneurship Symposium: Necessity-Driven Innovation! Join her and others online on Thursday, March 27, from 3–4 p.m. ET for an inspiring discussion on:✨ How solving your own problem can lead to innovative ideas that help others ✨ The challenges innovators face when bringing their ideas to market ✨ Resources to support your innovation journeyDon't miss this opportunity to gain insights and connect with fellow entrepreneurs: https://lnkd.i...","published_at":"2025-03-18T15:33:08Z","canonical_url":"https://wefunder.com/feed/180547"},{"id":180040,"entity_id":"wefunder:feed_item:180040","title":"NasaClip going public on 3/12, (re)invest now to ensure your spot!","preview":"­­We are\u0026nbsp;thrilled\u0026nbsp;to announce that we have raised more than\u0026nbsp;$275K on Wefunder\u0026nbsp;and more than\u0026nbsp;$3M in our seed round!!\u0026nbsp;We will be going public on\u0026nbsp;wefunder.com/nasaclip\u0026nbsp;on\u0026nbsp;March 12, 2025. Please make sure you invest before this date to ensure you have a spot in the round, we expect it to fill up fast.\u0026nbsp;Below is some background information you can share with your network.\u0026nbsp;NasaClip\u0026nbsp;is a novel, physician-designed, intranasal drug delivery de...","published_at":"2025-03-03T17:37:47Z","canonical_url":"https://wefunder.com/feed/180040"},{"id":179728,"entity_id":"wefunder:feed_item:179728","title":"Dr. Clayborne Presenting at CWRU Veal Institute for Entrepreneurship today (2/21)","preview":"Dr. Clayborne was invited back to her medical school, Case Western Reserve University School of Medicine participate in the CWRU Veale Institute for Entrepreneurship Speaker Series at Sears think[box] at Case Western Reserve University to share her startup journey with NasaClip. The session will be moderated by Case Western Reserve University School of Medicine student Zain Khawaja who is helping lead the due diligence process on NasaClip for our CWRU Veale Institute for Entrepreneurship Alum...","published_at":"2025-02-21T16:09:56Z","canonical_url":"https://wefunder.com/feed/179728"},{"id":179637,"entity_id":"wefunder:feed_item:179637","title":"\u0026gt; $235K invested on Wefunder!! 5 Reasons to (Re)Invest in NasaClip","preview":"NasaClip is revolutionizing how we manage nosebleeds, and we’re gaining momentum fast. Here’s why now is the perfect time to invest as we transform the $5B nosebleed care market and beyond:1️⃣🔬 Game-Changing, Versatile SolutionNasaClip is the first and only adjustable, hands-free nosebleed rescue device designed by an ER physician. It’s intuitive, mess-free, and effective for both medical professionals and everyday consumers.2️⃣🌍 Massive Market OpportunityNosebleed treatments represent a $5B ...","published_at":"2025-02-20T15:58:59Z","canonical_url":"https://wefunder.com/feed/179637"},{"id":179163,"entity_id":"wefunder:feed_item:179163","title":"INNOVATE Washington Unboxing!","preview":"NasaClip is in INNOVATE® Washington - Showcasing DMV Innovators and Innovations! Thank you DC Startup \u0026 Tech Week. This unboxing has me so excited and happy to share our healthcare and technology #startup journey!\u0026nbsp;YOU can help bring NasaClip to more homes - and own a stake in our success! Invest or increase your investment today and join us in transforming more situations from chaos to calm\u0026nbsp;\u0026nbsp;wefunder.com/nasaclip\u0026nbsp;","published_at":"2025-01-30T18:34:02Z","canonical_url":"https://wefunder.com/feed/179163"},{"id":179018,"entity_id":"wefunder:feed_item:179018","title":"From Chaos to Calm: a lifesaver for me and my daughter! 🩸","preview":"Recently, my daughter woke up with a nosebleed—it was everywhere: her bedding, carpet, and pajamas.\u0026nbsp;\u0026nbsp;What could have been total chaos during the morning rush was quickly turned around. Thankfully, I had a NasaClip handy. I popped it on, and within 10 minutes, the bleeding stopped. TRUE STORY!\u0026nbsp;As an ER physician, I’ve used this tool countless times in the hospital to stop bleeding for patients. But using it at home—for my own child—was even more rewarding. It made everything so ...","published_at":"2025-01-24T20:48:18Z","canonical_url":"https://wefunder.com/feed/179018"},{"id":178759,"entity_id":"wefunder:feed_item:178759","title":"Dr. Liz gets 1st Place in Market Pulse Pitch!","preview":"1st Place, $7,000 check and the BEST part was Dr. Liz won the #pitch competition in front of her two daughters and her parents!This week, Dr. Liz had the incredible opportunity to participate in the Market Pulse Pitch Series, hosted in Howard County, Maryland. As one of the region’s premier platforms for innovation, the Market Pulse Pitch Series connects investors with forward-thinking companies shaping the future of the life sciences industry.The event brought together leaders in healthcare,...","published_at":"2025-01-14T20:45:24Z","canonical_url":"https://wefunder.com/feed/178759"}],"provenance":{"source":"wefunder_public_company_profile","as_of":"2026-06-13T04:30:14Z","claims":{"total_amount_raised":{"source":"FrontCompanySummary#amount_raised","last_verified_at":"2026-06-12T05:01:17Z","as_of":"2026-06-13T04:30:14Z","confidence":"high"},"total_investors":{"source":"FrontCompanySummary#number_of_investors","last_verified_at":"2026-06-12T05:01:17Z","as_of":"2026-06-13T04:30:14Z","confidence":"high"},"active_raise_states":{"source":"Fundraise.visible(nil, nil)","last_verified_at":"2025-03-19T19:40:11Z","as_of":"2026-06-13T04:30:14Z","confidence":"high"},"latest_fundraise_state":{"source":"Fundraise.visible(nil, nil).order(funding_started_at)","last_verified_at":"2025-03-19T19:40:11Z","as_of":"2026-06-13T04:30:14Z","confidence":"medium"}}}}}}